Researchers develop combined data model to better evaluate for mild cognitive impairment

A new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status of individuals.

Cognitive decline is one of the most concerning behavioral symptoms associated with Alzheimer's disease (AD). The ability to efficiently distinguish individuals with (MCI) from individuals who have normal cognition (NC) is crucial for early detection of AD.

In the past, different tests have been used to evaluate MCI. The Mini-Mental State Examination (MMSE) is a commonly used screening tool for dementia. Additionally, the Wechsler Memory Scale Logical memory (LM) test is a neuropsychological test that assesses verbal memory and is considered sensitive for AD. Neuroimaging, such as (MRI) provide biologic evidence that is neurodegenerative.

Researchers from Boston University School of Medicine (BUSM) used the National Alzheimer's Coordinating Center database to select data from 386 subjects who were clinically diagnosed with either NC or MCI. Subjects had previously completed the MMSE, the LM test and an MRI. They then developed a machine learning framework that allowed for the combination of models generated from individual MRI scans along with models developed on MMSE and LM test results to predict clinical diagnosis of . "Our findings indicate that this framework can better predict MCI as it has the capability to combine needed information from multimodal data resource," explained corresponding author Vijaya B. Kolachalama, Ph.D., assistant professor of medicine at BUSM.

According to Kolachalama and Rhoda Au, Ph.D., professor of anatomy and neurobiology at BUSM and director of neuropsychology at the Framingham Heart Study, this study is a proof of principle that multimodal fusion of models developed using MRI scans, and other traditional test data is feasible and can better predict cognitive impairment. The fusion was superior to the individual models alone and achieved an overall accuracy of over 90 percent.

These findings appear online in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.


Explore further

Evaluation and treatment of depression may reverse memory and cognitive difficulties

Provided by Boston University School of Medicine
Citation: Researchers develop combined data model to better evaluate for mild cognitive impairment (2018, October 4) retrieved 16 February 2019 from https://medicalxpress.com/news/2018-10-combined-mild-cognitive-impairment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more